BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23049793)

  • 1. P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.
    Chen MB; Wu XY; Yu R; Li C; Wang LQ; Shen W; Lu PH
    PLoS One; 2012; 7(9):e45388. PubMed ID: 23049793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis.
    Xu HY; Xu WL; Wang LQ; Chen MB; Shen HL
    PLoS One; 2014; 9(4):e95371. PubMed ID: 24740294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.
    Chow OS; Kuk D; Keskin M; Smith JJ; Camacho N; Pelossof R; Chen CT; Chen Z; Avila K; Weiser MR; Berger MF; Patil S; Bergsland E; Garcia-Aguilar J
    Ann Surg Oncol; 2016 Aug; 23(8):2548-55. PubMed ID: 27020587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of TP53 status for predicting response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Chen MB; Zhu YQ; Xu JY; Wang LQ; Liu CY; Ji ZY; Lu PH
    PLoS One; 2012; 7(6):e39655. PubMed ID: 22768103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peroxiredoxin I in rectal cancer and related to p53 status.
    Chen MF; Lee KD; Yeh CH; Chen WC; Huang WS; Chin CC; Lin PY; Wang JY
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):868-78. PubMed ID: 20732753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin use on neoadjuvant chemoradiotherapy for rectal cancer: a meta-analysis with trial sequential analysis.
    Wang B; Huang Y
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):2161-2171. PubMed ID: 32328776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer.
    Esposito G; Pucciarelli S; Alaggio R; Giacomelli L; Marchiori E; Iaderosa GA; Friso ML; Toppan P; Chieco-Bianchi L; Lise M
    Ann Surg Oncol; 2001 May; 8(4):311-8. PubMed ID: 11352304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
    Jakob C; Liersch T; Meyer W; Becker H; Baretton GB; Aust DE
    World J Gastroenterol; 2008 Feb; 14(7):1060-6. PubMed ID: 18286688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis.
    Lopez-Crapez E; Bibeau F; Thézenas S; Ychou M; Simony-Lafontaine J; Thirion A; Azria D; Grenier J; Senesse P
    Br J Cancer; 2005 Jun; 92(12):2114-21. PubMed ID: 15956964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
    Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
    Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis.
    Zhang SS; Huang QY; Yang H; Xie X; Luo KJ; Wen J; Cai XL; Yang F; Hu Y; Fu JH
    Ann Surg Oncol; 2013 Jul; 20(7):2419-27. PubMed ID: 23515910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.
    Kelley ST; Coppola D; Yeatman T; Marcet J
    Clin Colorectal Cancer; 2005 Jul; 5(2):114-8. PubMed ID: 16098252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis.
    Peng J; Lv J; Peng J
    Int J Colorectal Dis; 2021 Aug; 36(8):1781-1790. PubMed ID: 33760952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.
    El Otmani I; El Agy F; El Baradai S; Bouguenouch L; Lahmidani N; El Abkari M; Benajah DA; Toughrai I; El Bouhaddouti H; Mouaqit O; Ibn Majdoub Hassani K; Mazaz K; Benjelloun EB; Ousadden A; El Rhazi K; Bouhafa T; Benbrahim Z; Ouldim K; Ibrahimi SA; Ait Taleb K; Chbani L
    Dis Markers; 2020; 2020():8459303. PubMed ID: 31998419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
    O'Connell E; Reynolds IS; McNamara DA; Prehn JHM; Burke JP
    Surg Oncol; 2020 Sep; 34():57-62. PubMed ID: 32891354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
    Rombouts AJM; Hugen N; Verhoeven RHA; Elferink MAG; Poortmans PMP; Nagtegaal ID; de Wilt JHW
    Eur J Surg Oncol; 2018 Jul; 44(7):1018-1024. PubMed ID: 29678303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis.
    Hur H; Tulina I; Cho MS; Min BS; Koom WS; Lim JS; Ahn JB; Kim NK
    Dis Colon Rectum; 2016 Dec; 59(12):1174-1182. PubMed ID: 27824703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.